Citigroup’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-102,300
| Closed | -$18.1M | – | 7845 |
|
|
2020
Q1 | $18.1M | Sell |
102,300
-278,500
| -73% | -$52.4M | 0.02% | 795 |
|
|
2019
Q4 | $72.8M | Sell |
380,800
-212,400
| -36% | -$38.3M | 0.05% | 343 |
|
|
2019
Q3 | $99.8M | Sell |
593,200
-16,800
| -3% | -$2.74M | 0.08% | 229 |
|
|
2019
Q2 | $102M | Buy |
610,000
+164,800
| +37% | +$22.8M | 0.08% | 226 |
|
|
2019
Q1 | $65.2M | Sell |
445,200
-155,200
| -26% | -$22.5M | 0.06% | 300 |
|
|
2018
Q4 | $80.3M | Buy |
600,400
+272,800
| +83% | +$44.7M | 0.08% | 240 |
|
|
2018
Q3 | $62.4M | Buy |
327,600
+104,700
| +47% | +$19.2M | 0.06% | 314 |
|
|
2018
Q2 | $37.2M | Buy |
222,900
+18,600
| +9% | +$2.99M | 0.03% | 466 |
|
|
2018
Q1 | $34.4M | Sell |
204,300
-123,500
| -38% | -$20.7M | 0.03% | 527 |
|
|
2017
Q4 | $53.6M | Buy |
327,800
+6,800
| +2% | +$1.22M | 0.04% | 407 |
|
|
2017
Q3 | $65.8M | Buy |
321,000
+47,100
| +17% | +$11M | 0.05% | 308 |
|
|
2017
Q2 | $66.6M | Sell |
273,900
-157,600
| -37% | -$37M | 0.06% | 259 |
|
|
2017
Q1 | $103M | Sell |
431,500
-101,596
| -19% | -$23.7M | 0.09% | 160 |
|
|
2016
Q4 | $112M | Buy |
533,096
+109,564
| +26% | +$22.7M | 0.1% | 180 |
|
|
2016
Q3 | $97.5M | Buy |
423,532
+260,400
| +160% | +$63.6M | 0.09% | 189 |
|
|
2016
Q2 | $37.7M | Buy |
163,132
+78,700
| +93% | +$18.1M | 0.04% | 400 |
|
|
2016
Q1 | $22.6M | Sell |
84,432
-37,534
| -31% | -$10.7M | 0.03% | 548 |
|
|
2015
Q4 | $38.1M | Buy |
121,966
+26,128
| +27% | +$7.78M | 0.04% | 459 |
|
|
2015
Q3 | $26.1M | Sell |
95,838
-213,472
| -69% | -$65.6M | 0.02% | 597 |
|
|
2015
Q2 | $93.9M | Buy |
309,310
+170,312
| +123% | +$50.8M | 0.08% | 220 |
|
|
2015
Q1 | $41.4M | Sell |
138,998
-181,669
| -57% | -$51.8M | 0.04% | 424 |
|
|
2014
Q4 | $82.5M | Buy |
320,667
+148,533
| +86% | +$37.1M | 0.07% | 265 |
|
|
2014
Q3 | $41.5M | Sell |
172,134
-22,366
| -11% | -$5.01M | 0.04% | 462 |
|
|
2014
Q2 | $43M | Sell |
194,500
-75,300
| -28% | -$15.6M | 0.04% | 411 |
|
|
2014
Q1 | $55.5M | Buy |
269,800
+197,800
| +275% | +$39.2M | 0.06% | 291 |
|
|
2013
Q4 | $12.1M | Sell |
72,000
-14,900
| -17% | -$2.33M | 0.01% | 1101 |
|
|
2013
Q3 | $12.5M | Buy |
86,900
+54,300
| +167% | +$7.23M | 0.01% | 1004 |
|
|
2013
Q2 | $4.12M | Buy |
+32,600
| New | +$3.69M | ﹤0.01% | 1793 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Citigroup's AGN Position: Q2 2020 in Review
Citigroup sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,925,753 shares — an estimated $1.4B sold.
Citigroup first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.4B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Citigroup reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Citigroup sold 7,925,753 Allergan plc shares in Q2 2020, an estimated $1.4B.
- Citigroup first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Citigroup's Allergan plc position peaked at $1.4B in Q1 2020.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Citigroup's 13F filing for Q2 2020, filed 12 Aug 2020.